BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34413147)

  • 21. Influence of corticosteroid treatment on CXCR4 expression in DLBCL.
    Martin S; Viertl D; Janz A; Habringer S; Keller U; Schottelius M
    EJNMMI Res; 2023 May; 13(1):40. PubMed ID: 37162652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using
    Baum RP; Schuchardt C; Singh A; Chantadisai M; Robiller FC; Zhang J; Mueller D; Eismant A; Almaguel F; Zboralski D; Osterkamp F; Hoehne A; Reineke U; Smerling C; Kulkarni HR
    J Nucl Med; 2022 Mar; 63(3):415-423. PubMed ID: 34168013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicity.
    Kamaldeep ; Thapa P; Wanage G; Tervankar S; Kaisar S; Ranade R; Basu S; Das T; Banerjee S
    Nucl Med Commun; 2021 Oct; 42(10):1076-1084. PubMed ID: 34528928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
    Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
    Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
    Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
    Med Phys; 2016 Oct; 43(10):5279. PubMed ID: 27782699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.
    Belli ML; Mezzenga E; Di Iorio V; Celli M; Caroli P; Canali E; Matteucci F; Tardelli E; Grassi I; Sansovini M; Nicolini S; Severi S; Cremonesi M; Ferrari M; Paganelli G; Sarnelli A
    J Vis Exp; 2020 Apr; (158):. PubMed ID: 32391816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic Malignancies.
    Matesan M; Fisher DR; Wong R; Gopal AK; Green DJ; Sandmaier BM; Bensinger W; Pagel JM; Orozco J; Press OW; Cassaday RD; Hutchinson E; Wanner M; Pal S; Thostenson C; Rajendran JG
    J Nucl Med; 2020 Sep; 61(9):1300-1306. PubMed ID: 32169919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (177)Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model.
    Beykan S; Dam JS; Eberlein U; Kaufmann J; Kjærgaard B; Jødal L; Bouterfa H; Bejot R; Lassmann M; Jensen SB
    EJNMMI Res; 2016 Dec; 6(1):50. PubMed ID: 27294582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate
    Blakkisrud J; Holtedahl JE; Løndalen A; Dahle J; Bach-Gansmo T; Holte H; Nygaard S; Kolstad A; Stokke C
    J Nucl Med; 2018 Apr; 59(4):704-710. PubMed ID: 28848035
    [No Abstract]   [Full Text] [Related]  

  • 30. Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.
    Yadav MP; Ballal S; Tripathi M; Damle NA; Sahoo RK; Seth A; Bal C
    Nucl Med Commun; 2017 Jan; 38(1):91-98. PubMed ID: 27782913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated
    Gupta A; Shin JH; Lee MS; Park JY; Kim K; Kim JH; Suh M; Park CR; Kim YJ; Song MG; Jeong JM; Lee DS; Lee YS; Lee JS
    Mol Pharm; 2019 Apr; 16(4):1498-1506. PubMed ID: 30821463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies.
    Bartlett ML; Webb M; Durrant S; Morton AJ; Allison R; Macfarlane DJ
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1470-7. PubMed ID: 12397466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.
    Kuyumcu S; Kovan B; Sanli Y; Buyukkaya F; Has Simsek D; Özkan ZG; Isik EG; Ekenel M; Turkmen C
    Clin Nucl Med; 2021 Aug; 46(8):641-646. PubMed ID: 33883494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is a single late SPECT/CT based kidney
    Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M
    Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetry of
    Xu L; Meng Q; Yao X; Yang R; Zhang P; Li R; Wang F
    Appl Radiat Isot; 2022 Jan; 179():109975. PubMed ID: 34741954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma.
    Wiseman GA; White CA; Stabin M; Dunn WL; Erwin W; Dahlbom M; Raubitschek A; Karvelis K; Schultheiss T; Witzig TE; Belanger R; Spies S; Silverman DH; Berlfein JR; Ding E; Grillo-López AJ
    Eur J Nucl Med; 2000 Jul; 27(7):766-77. PubMed ID: 10952488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.
    Tran-Gia J; Salas-Ramirez M; Lassmann M
    J Nucl Med; 2020 Aug; 61(8):1178-1186. PubMed ID: 31862802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized
    Del Prete M; Arsenault F; Saighi N; Zhao W; Buteau FA; Celler A; Beauregard JM
    EJNMMI Phys; 2018 Oct; 5(1):25. PubMed ID: 30318563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel planar image-based method for bone marrow dosimetry in (177)Lu-DOTATATE treatment correlates with haematological toxicity.
    Svensson J; Rydén T; Hagmarker L; Hemmingsson J; Wängberg B; Bernhardt P
    EJNMMI Phys; 2016 Dec; 3(1):21. PubMed ID: 27654452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.